4526 — Riken Vitamin Share Price
- ¥106bn
- ¥96bn
- ¥96bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.07 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -6.82% | ||
| Dividend Yield (f) | 3.01% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.26 | ||
| Price to Tang. Book | 1.28 | ||
| Price to Free Cashflow | 101.98 | ||
| Price to Sales | 1.08 | ||
| EV to EBITDA | 8.26 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.89% | ||
| Return on Equity | 8.67% | ||
| Operating Margin | 6.93% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 79,231 | 88,750 | 91,484 | 95,582 | 96,300 | 104,600 | 112,900 | 4.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -70.33 | +42.17 | +17.53 | -27.26 | +26.75 | -22.73 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Riken Vitamin Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of food products. It operates through three business segments. The Domestic Food segment manufactures and sells household foods (processed foods for general households), commercial foods (processed foods for the commercial market), and processed food ingredients (ingredients for processed foods, food improvers, and vitamins for the food industry). The products include seaweed products, dressings, extracts and seasonings, food improvers, vitamins, and health functional products. The Domestic Chemical Products and Others segment manufactures and sells chemical product improvers and feed additives. The Overseas segment manufactures and sells food improvers, chemical product improvers, extracts, and seasonings, and distributes its products in Southeast Asia, South Asia, the Middle East, Oceania, Europe, Africa, North America, Central and South America, China, Taiwan, and South Korea.
Directors
- Kazuhiko Yamaki NEC (67)
- Nobuo Dotsu SMD (65)
- Tsutomu Mochizuki PRE (64)
- Satoshi Fujinaga IND (66)
- Seiji Akutsu DSL
- Masaaki Nakano DRC (60)
- Takumi Aoki DRC
- Takehiko Makinodan DRC (63)
- Shinichi Koyama MEO
- Takahiro Tomitori MDR (60)
- Toshiyuki Tanaka DHR
- Yasunori Iwasa DSL
- Takeo Yotsuzuka MEO
- Noriyuki Kawasaki DSL
- Tomoya Sato DSL
- Last Annual
- March 31st, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- August 27th, 1949
- Public Since
- October 2nd, 1961
- No. of Shareholders
- 40,994
- No. of Employees
- 1,887
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
Tokyo Stock Exchange
- Shares in Issue
- 29,032,681

- Address
- 1-6-1, Yotsuya, SHINJUKU-KU, 160-0004
- Web
- https://www.rikenvitamin.jp/
- Phone
- +81 353621311
- Auditors
- KPMG AZSA LLC
Latest News for 4526
Upcoming Events for 4526
Q3 2027 Riken Vitamin Co Ltd Earnings Release
Dividend For 4526.T - 63.0000 JPY
Similar to 4526
AFC-HD AMS Life Science
Tokyo Stock Exchange
Ahjikan
Tokyo Stock Exchange
Ajinomoto
Tokyo Stock Exchange
Akikawa Foods & Farms
Tokyo Stock Exchange
Ariake Japan
Tokyo Stock Exchange
FAQ
As of Today at 12:58 UTC, shares in Riken Vitamin are trading at ¥3,660. This share price information is delayed by 15 minutes.
Shares in Riken Vitamin last closed at ¥3,660 and the price had moved by +28.2% over the past 365 days. In terms of relative price strength the Riken Vitamin share price has outperformed the Nikkei 225 Index by +7.52% over the past year.
The overall consensus recommendation for Riken Vitamin is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Riken Vitamin dividend yield is 3.01% based on the trailing twelve month period.
Last year, Riken Vitamin paid a total dividend of ¥110, and it currently has a trailing dividend yield of 3.01%.Looking ahead, shares in Riken Vitamin are due to go ex-dividend on 2027-03-30 and the next dividend pay date is 2026-12-07.
Riken Vitamin are due to go ex-dividend on 2027-03-30 and the next dividend pay date is 2026-12-07. The historic dividend yield on Riken Vitamin shares is currently 3.01%.
To buy shares in Riken Vitamin you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥3,660, shares in Riken Vitamin had a market capitalisation of ¥106bn.
Here are the trading details for Riken Vitamin:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4526
Based on an overall assessment of its quality, value and momentum Riken Vitamin is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Riken Vitamin is ¥4,300. That is 17.49% above the last closing price of ¥3,660.
Analysts covering Riken Vitamin currently have a consensus Earnings Per Share (EPS) forecast of ¥303 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Riken Vitamin. Over the past six months, its share price has outperformed the Nikkei 225 Index by +28.87%.
As of the last closing price of ¥3,660, shares in Riken Vitamin were trading +18.4% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Riken Vitamin PE ratio based on its reported earnings over the past 12 months is 14.07. The shares last closed at ¥3,660.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Riken Vitamin's management team is headed by:
- Kazuhiko Yamaki - NEC
- Nobuo Dotsu - SMD
- Tsutomu Mochizuki - PRE
- Satoshi Fujinaga - IND
- Seiji Akutsu - DSL
- Masaaki Nakano - DRC
- Takumi Aoki - DRC
- Takehiko Makinodan - DRC
- Shinichi Koyama - MEO
- Takahiro Tomitori - MDR
- Toshiyuki Tanaka - DHR
- Yasunori Iwasa - DSL
- Takeo Yotsuzuka - MEO
- Noriyuki Kawasaki - DSL
- Tomoya Sato - DSL





